FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Pulmonary-Allergy Drugs Advisory Committee

Purpose

The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of pulmonary disease and diseases with allergic and/or immunologic mechanisms and makes appropriate recommendations to the Commissioner of Food and Drugs.

Meeting Information

Contact

Kristine Khuc, Pharm.D, R.Ph., Designated Federal Official
Advisors and Consultants Staff
Center for Drug Evaluation and Research
Food and Drug Administration,
5630 Fishers Lane, HFD-21
Rockville, Maryland 20857
(301) 827-7001
Fax: (301) 827-6776
E-mail: Kristine.Khuc@fda.hhs.gov

Committee Membership

The Committee shall consist of a core of 13 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of pulmonary medicine, allergy, clinical immunology, and epidemiology or statistics. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests.

Committee Resources

  • Committee Vacancies
  • Committee Charter
  • Roster (members)
  • FDA Advisory Committee Information Line
    1-800-741-8138
    (301) 443-0572 (local number)
    code: 3014512545
    Please call the Information Line for up-to-date information on meetings.

Related Links

 

to top arrow Back to Top     back arrow Human Drug Advisory Committees

PDF document PDF requires the free Adobe Acrobat Reader

Date created: September 2, 2008; updated: January 14, 2009